NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

TaiMed Biologics Inc (TWO: 4147)

 
4147 Technical Analysis
4
As on 8th May 2025 4147 STOCK Price closed @ 79.10 and we RECOMMEND Sell for LONG-TERM with Stoploss of 86.11 & Strong Sell for SHORT-TERM with Stoploss of 83.93 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

4147STOCK Price

Open 78.30 Change Price %
High 79.10 1 Day 0.10 0.13
Low 78.10 1 Week -0.90 -1.12
Close 79.10 1 Month -19.90 -20.10
Volume 374039 1 Year -8.50 -9.70
52 Week High 114.00 | 52 Week Low 66.80
 
TWO Taiwan Most Active Stocks
1815 29.20 2.28%
4541 51.20 1.79%
4931 86.40 -2.26%
8096 52.40 2.34%
4303 87.50 1.86%
3546 130.00 6.56%
5251 49.90 0.00%
6148 72.50 0.55%
3363 219.00 7.62%
6274 152.00 6.67%
 
TWO Taiwan Top Gainers Stocks
6651 89.10 10.00%
8054 77.10 9.99%
6233 22.05 9.98%
6596 108.00 9.98%
8121 20.45 9.95%
8121 20.45 9.95%
3213 110.50 9.95%
3663 55.30 9.94%
4129 94.00 9.94%
3540 29.90 9.93%
 
TWO Taiwan Top Losers Stocks
3202 3.96 -10.00%
6156 26.00 -6.47%
5014 12.75 -4.49%
5014 12.75 -4.49%
5601 37.60 -4.33%
3207 70.60 -4.21%
3491 346.00 -4.16%
4556 27.80 -3.97%
3672 18.55 -3.89%
4804 3.85 -3.27%
 
 
4147
Daily Charts
4147
Intraday Charts
Whats New @
Bazaartrend
4147
Free Analysis
 
4147 Important Levels Intraday
RESISTANCE81.03
RESISTANCE80.41
RESISTANCE80.03
RESISTANCE79.65
SUPPORT78.56
SUPPORT78.17
SUPPORT77.79
SUPPORT77.17
 
4147 Forecast May 2025
4th UP Forecast93.75
3rd UP Forecast89.05
2nd UP Forecast86.15
1st UP Forecast83.24
1st DOWN Forecast74.96
2nd DOWN Forecast72.05
3rd DOWN Forecast69.15
4th DOWN Forecast64.45
 
4147 Weekly Forecast
4th UP Forecast94.52
3rd UP Forecast89.57
2nd UP Forecast86.52
1st UP Forecast83.46
1st DOWN Forecast74.74
2nd DOWN Forecast71.68
3rd DOWN Forecast68.63
4th DOWN Forecast63.68
 
4147 Forecast2025
4th UP Forecast176.61
3rd UP Forecast145.34
2nd UP Forecast126.01
1st UP Forecast106.68
1st DOWN Forecast51.52
2nd DOWN Forecast32.19
3rd DOWN Forecast12.86
4th DOWN Forecast-18.41
 
 
4147 Other Details
Segment EQ
Market Capital 17560358912.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
4147 Address
4147
 
4147 Latest News
 
Your Comments and Response on TaiMed Biologics Inc
 
4147 Business Profile
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody that is in Phase II clinical trials for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase II clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which is in Phase I clinical trials for treating HIV infections; TMB-370, a bispecific neutralizing antibody that is in Phase I clinical trials to treat HIV infections; and TMB-380, a neutralizing HIV-1 antibody. The company was founded in 2007 and is headquartered in Taipei, Taiwan. Address: No. 607, Ruiguang Road, Taipei, Taiwan, 11492
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service